These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 22632535)
41. Beyond the short-term: clinical outcome and valve performance 2 years after transcatheter aortic valve implantation in 227 patients. Bleiziffer S; Mazzitelli D; Opitz A; Hettich I; Ruge H; Piazza N; Lange R J Thorac Cardiovasc Surg; 2012 Feb; 143(2):310-7. PubMed ID: 22137802 [TBL] [Abstract][Full Text] [Related]
42. Concomitant transcatheter aortic and mitral valve-in-valve replacements using transfemoral devices via the transapical approach: first case in United States. Paradis JM; Kodali SK; Hahn RT; George I; Daneault B; Koss E; Nazif TM; Leon MB; Williams MR JACC Cardiovasc Interv; 2013 Jan; 6(1):94-6. PubMed ID: 23347868 [No Abstract] [Full Text] [Related]
43. Comparison of hemodynamic performance of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis. Nombela-Franco L; Ruel M; Radhakrishnan S; Webb JG; Hansen M; Labinaz M; Thompson C; Fremes S; Dumont E; DeLarochellière R; Doyle D; Urena M; Mok M; Ribeiro HB; Roifman I; Watkins S; Dumesnil JG; Pibarot P; Rodés-Cabau J Am J Cardiol; 2013 Apr; 111(7):1026-33. PubMed ID: 23351465 [TBL] [Abstract][Full Text] [Related]
47. First percutaneous transcatheter aortic valve-in-valve implant with three year follow-up. Ruiz CE; Laborde JC; Condado JF; Chiam PT; Condado JA Catheter Cardiovasc Interv; 2008 Aug; 72(2):143-8. PubMed ID: 18655115 [TBL] [Abstract][Full Text] [Related]
48. Transapical transcatheter aortic valve for severe aortic regurgitation: expanding the limits. Wendt D; Kahlert P; Pasa S; El-Chilali K; Al-Rashid F; Tsagakis K; Dohle DS; Erbel R; Jakob H; Thielmann M JACC Cardiovasc Interv; 2014 Oct; 7(10):1159-67. PubMed ID: 25129668 [TBL] [Abstract][Full Text] [Related]
49. Transcatheter aortic valve implantation by the left axillary approach: a single-center experience. Laflamme M; Mazine A; Demers P; Lamarche Y; Ibrahim R; Asgar A; Cartier R Ann Thorac Surg; 2014 May; 97(5):1549-54. PubMed ID: 24462415 [TBL] [Abstract][Full Text] [Related]
50. Transseptal approach for the management of paravalvular regurgitation after transcatheter aortic valve replacement. Martinez CA; O'Neill B; Singh V; O'Neill WW Catheter Cardiovasc Interv; 2013 Oct; 82(4):E587-91. PubMed ID: 23008182 [TBL] [Abstract][Full Text] [Related]
51. Transcatheter aortic valve implantation (TAVI) in a patient with severe aortic insufficiency of aortic valve homograft. Huczek Z; Kochman J; Scisło P; Rymuza B; Kowalik R; Opolski G Kardiol Pol; 2013; 71(12):1325. PubMed ID: 24399597 [No Abstract] [Full Text] [Related]
52. Clinical outcome of transcatheter aortic valve implantation in patients with low-flow, low gradient aortic stenosis. Gotzmann M; Lindstaedt M; Bojara W; Ewers A; Mügge A Catheter Cardiovasc Interv; 2012 Apr; 79(5):693-701. PubMed ID: 21805576 [TBL] [Abstract][Full Text] [Related]
53. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. Détaint D; Lepage L; Himbert D; Brochet E; Messika-Zeitoun D; Iung B; Vahanian A JACC Cardiovasc Interv; 2009 Sep; 2(9):821-7. PubMed ID: 19778769 [TBL] [Abstract][Full Text] [Related]
54. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. Binder RK; Rodés-Cabau J; Wood DA; Mok M; Leipsic J; De Larochellière R; Toggweiler S; Dumont E; Freeman M; Willson AB; Webb JG JACC Cardiovasc Interv; 2013 Mar; 6(3):293-300. PubMed ID: 23517842 [TBL] [Abstract][Full Text] [Related]
55. Transcatheter aortic valve-in-valve implantation of a CoreValve in a degenerated stenotic Sapien heart valve prosthesis. Hoffmann R; Möllmann H; Lotfi S Catheter Cardiovasc Interv; 2013 Dec; 82(7):E922-5. PubMed ID: 22707435 [TBL] [Abstract][Full Text] [Related]
56. 5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. Cheung A; Webb JG; Barbanti M; Freeman M; Binder RK; Thompson C; Wood DA; Ye J J Am Coll Cardiol; 2013 Apr; 61(17):1759-66. PubMed ID: 23500301 [TBL] [Abstract][Full Text] [Related]
57. Transcatheter aortic valve implantation for severe regurgitation in native and degenerated bioprosthetic aortic valves. Sarkar K; Sardella G; Romeo F; De Benedictis M; Tarsia G; Iadanza A; Sharma SK; Barbanti M; Tamburino C; Ussia GP Catheter Cardiovasc Interv; 2013 Apr; 81(5):864-70. PubMed ID: 22997004 [TBL] [Abstract][Full Text] [Related]
58. Successful treatment of pure aortic insufficiency with transapical implantation of the JenaValve. Bleiziffer S; Mazzitelli D; Nöbauer C; Ried T; Lange R Thorac Cardiovasc Surg; 2013 Aug; 61(5):428-30. PubMed ID: 23344750 [TBL] [Abstract][Full Text] [Related]
59. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography. García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054 [TBL] [Abstract][Full Text] [Related]